Burkhard Ludewig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jul 21, 2021, 11:04 IST New Delhi: According to a recent research study, the Oxford-AstraZeneca COVID-19 vaccine, known in India as Covishield, provides strong protection that may last a lifetime. The vaccination, in addition to creating virus-busting antibodies, establishes training camps in the body for search-and-destroy T-cells that can target even novel strains, according to The Sun in the United Kingdom. It implies that the body may keep producing these essential cells long after the antibodies have worn off, perhaps for the remainder of your life, according to the study. T-cell protection is a key feature of adenovirus vaccinations like the Oxford and J & J jabs, according to scientists from Oxford, UK, and Switzerland, writing in the journal Nature.

United kingdomNew delhiPaul klenermanBurkhard ludewigOxford nuffield department of medicineCantonal hospitalNuffield departmentஒன்றுபட்டது கிஂக்டம்புதியது டெல்ஹிஆக்ஸ்ஃபர்ட் நுஃபையீல்ட் துறை ஆஃப் மருந்துநுஃபையீல்ட் துறை